This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stereotaxis To Highlight Enhanced Technology And Results At HRS 2013 In Denver

Stocks in this article: STXS

ST. LOUIS, May 7, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced that it will highlight the milestones and clinical results achieved with its cutting-edge Epoch™ platform, as well as preview enhancements to the Epoch suite, at the 34 th Annual Heart Rhythm Society (HRS) Scientific Sessions, May 8-11, 2013 in Denver, CO. The Company has surpassed an industry leading 60,000 procedures on its remote magnetic navigation system, more than 10,000 of which were performed in 2012.

"We are excited to share with the HRS audience how our technologies have transformed the practice of electrophysiology (EP) for hundreds of physician users and what is ahead for us in terms of product innovation," says William Mills, Stereotaxis Board Chairman and interim Chief Executive Officer. "The safety of our robotic solutions is second to none, and the evidence continues to grow on other significant clinical and economic benefits. We remain focused on advancing and refining our magnetic and robotic navigation systems for optimal performance."

Mr. Mills says the Company's vision is to become the new standard of care in EP procedures across the globe and has already succeeded in doing so in countries such as Finland, where all five of its teaching hospitals, who collectively handle the vast majority of the country's complex EP cases, now routinely use Stereotaxis innovations.

More than 460 EPs worldwide utilize Stereotaxis technology today. Three of these physicians will speak to their personal experiences with the Epoch platform, including the platform's impact on reducing procedure time, increasing patient volume and other favorable results through in-booth presentations (Booth 1802) at the following times:

  • May 9, 3:30-4:00 p.m. – Dr. Tamas Szili-Torok, Erasmus Medical Center
  • May 10, 10:00-10:30 a.m. – Dr. William Spear, Advocate Christ Medical Center
  • May 10, 10:30-11:00 a.m. – Dr. J. Peter Weiss, Intermountain Medical Center

Furthermore, the Robotic EP Society, conceived by Stereotaxis physician users and other robotic advocates at the 2012 HRS Scientific Sessions, will convene during the three-day event. The group's purpose is to exchange best practices and clinical insights, while building a network of experts intent on moving robotics from early adopters to generalized usage in electrophysiology.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs